Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 9
88
Views
3
CrossRef citations to date
0
Altmetric
Pharmacogenetics

Genetic polymorphism of Arg213His variant in the SULT1A1 gene is associated with reduced susceptibility to lung cancer in North Indian population

, & ORCID Icon
Pages 1071-1080 | Received 15 Jun 2021, Accepted 28 Jul 2021, Published online: 17 Aug 2021

References

  • Arslan S. 2010. Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. Biochem Genet. 48(11–12):987–994.
  • Arslan S, Silig Y, Pinarbasi H. 2009. An investigation of the relationship between SULT1A1 Arg(213)His polymorphism and lung cancer susceptibility in a Turkish population. Cell Biochem Funct. 27(4):211–215.
  • Bahl C, Sharma S, Singh N, Behera D. 2017. Association study between genetic variations in Axin2 gene and lung cancer risk in North Indian population: a multiple interaction analysis. Tumor Biol. 39(4):1–18.
  • Banoglu E. 2000. Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Curr Drug Metab. 1(1):1–30.
  • Bardakci F, Arslan S, Bardakci S, Binatli AO, Budak M. 2008. Sulfotransferase 1A1 (SULT1A1) polymorphism and susceptibility to primary brain tumors. J Cancer Res Clin Oncol. 134(1):109–114.
  • Blanchard RL, Freimuth RR, Buck J, Weinshilboum RM, Coughtrie MW. 2004. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenet Genomics. 14(3):199–211.
  • Boccia S, Persiani R, La Torre G, Rausei S, Arzani D, Gianfagna F, Romano-Spica V, D’Ugo D, Ricciardi G. 2005. Sulfotransferase 1A1 polymorphism and gastric cancer risk: a pilot case-control study. Cancer Lett. 229(2):235–243.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
  • Chung YT, Hsieh LL, Chen IH, Liao CT, Liou SH, Chi CW, Ueng YF, Liu TY. 2009. Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese. Carcinogenesis. 30(2):286–294.
  • Coughtrie MW, Sharp S, Maxwell K, Innes NP. 1998. Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem Biol Interact. 109(1–3):3–27.
  • da Silva Santos S, Koifman RJ, Ferreira RM, Diniz LF, Brennan P, Boffetta P, Koifman S. 2012. SULT1A1 genetic polymorphisms and the association between smoking and oral cancer in a case-control study in Brazil. Front Oncol. 2:183.
  • Dash R, Ali M, Dash N, Azad M, Kalam A, Hosen SM, Hannan M, Moon IS. 2019. Structural and dynamic characterizations highlight the deleterious role of SULT1A1 R213H polymorphism in substrate binding. Int J Mol Sci. 20(24):6256.
  • de Groot PM, Wu CC, Carter BW, Munden RF. 2018. The epidemiology of lung cancer. Transl Lung Cancer Res. 7(3):220–233.
  • Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, et al. 2004. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer. 110(4):598–604.
  • Ihsan R, Chauhan PS, Mishra AK, Yadav DS, Kaushal M, Sharma JD, Zomawia E, Verma Y, Kapur S, Saxena S. 2011. Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non-smokers in lung cancer. PloS One. 6(12):e29431.
  • Jones AL, Hume R, Bamforth KJ, Coughtrie MW. 1992. Estrogen and phenol sulfotransferase activities in human fetal lung. Early Hum Dev. 28(1):65–77.
  • Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, Nakata S, Yamanaka H, Suzuki K. 2008. Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case–control study of familial prostate cancer in a Japanese population. Int Urol Nephrol. 40(4):947–951.
  • Kumar K, Kandula M, Bhavani V, Laxmi A, Jamil K. 2013. Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk: a case-control study in South India. Am J Cancer Sci. 2(2):108–115.
  • Lee H, Wang Q, Yang F, Tao P, Li H, Huang Y, Li JY. 2012. SULT1A1 Arg213His polymorphism, smoked meat, and breast cancer risk: a case-control study and meta-analysis. DNA Cell Biol. 31(5):688–699.
  • Li Y, Lindsay J, Wang LL, Zhou SF. 2008. Structure, function and polymorphism of human cytosolic sulfotransferases. Curr Drug Metab. 9(2):99–105.
  • Liang G, Miao X, Zhou Y, Tan W, Lin D. 2003. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking. Carcinogenesis. 25(5):773–778.
  • Liao SG, Liu L, Zhang YY, Wang Y, Wang YJ. 2012. SULT1A1 Arg213His polymorphism and lung cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 13(2):579–583.
  • Lilla C, Risch A, Kropp S, Chang-Claude J. 2005. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case–control study. Breast Cancer Res. 7(2):R229.
  • Nowell S, Coles B, Sinha R, MacLeod S, Ratnasinghe DL, Stotts C, Kadlubar FF, Ambrosone CB, Lang NP. 2002. Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutat Res-Fund Mol Mech Mutagen. 506–507:175–185.
  • Nowell S, Ratnasinghe DL, Ambrosone CB, Williams S, Teague-Ross T, Trimble L, Runnels G, Carrol A, Green B, Stone A, et al. 2004. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 13(2):270–276.
  • Pachouri SS, Sobti RC, Kaur P, Singh J, Gupta SK. 2006. Impact of polymorphism in sulfotransferase gene on the risk of lung cancer. Cancer Genet Cytogenet. 171(1):39–43.
  • Peng CT, Chen JC, Yeh KT, Wang YF, Hou MF, Lee TP, Shih MC, Chang JY, Chang JG. 2003. The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int J Mol Med. 11(1):85–89.
  • Rouprêt M, Cancel-Tassin G, Comperat E, Fromont G, Sibony M, Molinié V, Allory Y, Triau S, Champigneulle J, Gaffory C, et al. 2007. Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma. Cancer Epidemiol Biomarkers Prev. 16(11):2500–2503.
  • Sak K, Kasemaa K, Everaus H. 2019. Polymorphisms in COMT and SULT1A1 genes and chronic lymphocytic leukemia risk in Estonia. EJMO, 3(4):281–288.
  • Tamaki Y, Arai T, Sugimura H, Sasaki T, Honda M, Muroi Y, Matsubara Y, Kanno S, Ishikawa M, Hirasawa N, et al. 2011. Association between cancer risk and drug metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in Japanese cases of lung cancer. Drug Metab Pharmacokinet. 26(5):516–522.
  • Tasnim T, Al-Mamun MMA, Nahid NA, Islam MR, Apu MNH, Bushra MU, Rabbi SNI, Nahar Z, Chowdhury JA, Ahmed MU, et al. 2017. Genetic variants of SULT1A1 and XRCC1 genes and risk of lung cancer in Bangladeshi population. Tumour Biol. 39(11):1010428317729270.
  • Wang YH, Juang GD, Hwang TI, Shen CH, Shao KY, Chiou HY. 2008. Genetic polymorphism of sulfotransferase 1A1, cigarette smoking, hazardous chemical exposure and urothelial cancer risk in a Taiwanese population. Int J Urol. 15(12):1029–1034.
  • Wang Y, Spitz MR, Tsou AMH, Zhang K, Makan N, Wu X. 2002. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer. 35(2):137–142.
  • Wang XC, Wang J, Tao HH, Zhang C, Xu LF. 2017. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses. Int J Occup Med Environ Health. 30(5):791–802.
  • Xiao J, Zheng Y, Zhou Y, Zhang P, Wang J, Shen F, Fan L, Kolluri VK, Wang W, Yan X, et al. 2014. Sulfotransferase SULT1A1 Arg213His polymorphism with cancer risk: a meta-analysis of 53 case-control studies. PloS One. 9(9):e106774.
  • Zheng L, Wang Y, Schabath MB, Grossman HB, Wu X. 2003. Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study. Cancer Lett. 202(1):61–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.